As Zepbound dominates headlines as a new obesity-fighting drug, a nutritionist warns that weight loss shouldn’t be the only goal


(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)

(THE CONVERSATION) If the buzz surrounding a medication could elevate it to celebrity status, then Zepbound is reaching Taylor Swift rank.

.apg-support-local-wrapper {
border-radius: 5px;
background-color: #E6E6E6;
padding: 10px;
}

.apg-support-local-wrapper p {
padding: 5px;
font-weight:bold;
/* override other site style */
margin: 0 !important;
font-size: 2rem;
}

.apg-support-local-wrapper h1 {
text-align: center;
/* override other site styles */
margin: 0 !important;
}

.apg-support-local-wrapper a {
font-family: verdana;
font-weight: 900;
font-size: 25px;
line-height: 20px;
color: white;
background-color: #FF6600;
padding: 10px;
border-radius: 15px;
box-shadow: 2px 3px 5px #888888;
text-decoration: none;
display: table-cell;
}

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more.


Leave a Reply

Your email address will not be published. Required fields are marked *